5. Dow’s price per share on December 11, 2015 was $54.91 and DuPont’s was $74.55. Dow shares outstanding were 1.16
billion and DuPont’s outstanding shares were .876 billion. Assume anticipated annual cost synergies are $ 3.0 billion in
perpetuity and DowDuPont’s cost of capital is 10%. What is DowDuPont’s total market cap excluding synergy? What
is the market cap including synergy using the zero growth method of valuation (see Chapter 7)?
Answer:
Dow’s market cap on 12.11.15 without synergy = $54.91 x 1.16 = $63.75billion
THE ELUSIVE ISSUE OF PRICE
Key Points:
• The acquirer’s cost often is more than what it pays target investors per share
• Additional costs include liabilities assumed by the buyer
• Assumed liabilities can be especially onerous if their future cost is difficult to estimate
• Negotiators often focus on minimizing such risk
______________________________________________________________________
The growth of cloud computing and the growing connectivity in our lives have pressured semiconductor2 makers to
achieve greater economies of scale to drive down costs and to offer a broader array of products ranging from commodity–
like to highly complex chips. These market forces have resulted in an ongoing consolidation within the industry. A recent
example of such consolidation is Intel’s (the world’s largest chipmaker) acquisition of Altera, an integrated circuits
manufacturer, for $16.7 billion. Intel’s interest centered on Altera’s programmable chips, a higher margin product whose
sales would help offset the declining personal computer market. Altera faced substantial capital expenditures to remain
competitive and being acquired represented a reasonable way to maximize shareholder wealth.
What follows is a description of events that transpired between Altera and Intel beginning in late 2014 and ending in
mid-2015 in a signed merger agreement. These events illustrate common negotiating tactics used by potential acquirers and
target boards and senior managers to hammer out M&A agreements.3
Given their long standing business relationship dating back to the late 1980s, it was easy for Intel’s CEO, Brian M.
Krazanich, to approach Altera’s CEO, John P. Daane, in late 2014 to discuss a commercial licensing deal. During the
conversation, Mr. Krazanich expressed Intel’s interest in acquiring the firm but he refrained from discussing a price range.
Aware of his fiduciary responsibility to shareholders, Mr. Daane said he would bring Intel’s expression of interest in buying
Altera to the firm’s board of directors.
Discussions during the early phase of the negotiating process are often nuanced. Any reference to purchase price by the
potential acquirer is usually verbal, vague, expressed in a range or formula (i.e., multiple of earnings), and conditioned on
performing “adequate” due diligence. The start date, length, and intrusiveness of due diligence often becomes a means for
both parties to leverage their positions. Sellers routinely move aggressively to get the buyer to state as high an offer price
with as few caveats as possible before granting the buyer the right to examine detailed financial statements, operations, etc.
Buyers use the absence of proprietary information as a reason for giving a price estimate as a range or formula or subject to
conditions allowing for revision of the initial offer price based on the outcome of due diligence.
Three weeks had passed before the two CEOs talked again. In the interim, Altera’s board hired financial advisor
Goldman Sachs. In mid-December the two met again with Mr. Krazanich willing to indicate a price range of $14 to $15
billion or $45 to $48 per share, subject to Intel performing due diligence. Mr. Daane stated that the price was too low and
that the firm would not enter due diligence unless Intel revised its offer up by at least $1 billion.
2 Used in such products as computers, cell phones, appliances, and medical equipment, semiconductors (usually composed
of silicon) conduct electricity more than an insulator but less than a pure conductor.
3 The source for this information is found in Altera’s Definitive Proxy Statement (Schedule 14A) filed with the SEC on
August 24, 2015.